US Supreme Court overturns Federal Circuit patent exhaustion stance in Impression v Lexmark
The US Supreme Court has ruled that patents rights in a product are exhausted after sale in the US or internationally, in a decision that included some strongly-worded pushback of the Federal Circuit. Pharmaceutical companies could be particularly affected because of their downstream licensing models
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
